CX Institutional Has $99,000 Stake in Select Medical Holdings Corporation $SEM

CX Institutional lessened its stake in shares of Select Medical Holdings Corporation (NYSE:SEM) by 92.0% during the third quarter, Holdings Channel reports. The fund owned 7,675 shares of the health services provider’s stock after selling 87,668 shares during the quarter. CX Institutional’s holdings in Select Medical were worth $99,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of SEM. Y Intercept Hong Kong Ltd acquired a new position in shares of Select Medical during the second quarter worth approximately $1,319,000. Strs Ohio acquired a new position in Select Medical during the first quarter worth $773,000. Intech Investment Management LLC lifted its stake in shares of Select Medical by 21.2% in the first quarter. Intech Investment Management LLC now owns 176,721 shares of the health services provider’s stock valued at $2,951,000 after buying an additional 30,892 shares in the last quarter. Sivik Global Healthcare LLC grew its holdings in shares of Select Medical by 50.0% during the second quarter. Sivik Global Healthcare LLC now owns 300,000 shares of the health services provider’s stock valued at $4,554,000 after buying an additional 100,000 shares during the last quarter. Finally, KLP Kapitalforvaltning AS increased its position in shares of Select Medical by 15.9% during the second quarter. KLP Kapitalforvaltning AS now owns 24,000 shares of the health services provider’s stock worth $364,000 after acquiring an additional 3,300 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Stock Performance

Shares of SEM opened at $15.16 on Tuesday. The stock has a 50 day moving average of $14.57 and a 200 day moving average of $13.86. The company has a market capitalization of $1.88 billion, a price-to-earnings ratio of 17.62, a PEG ratio of 0.53 and a beta of 1.26. Select Medical Holdings Corporation has a 12 month low of $11.65 and a 12 month high of $20.83. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.33 billion. Select Medical had a return on equity of 7.41% and a net margin of 2.05%.The business’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.43 EPS. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. As a group, sell-side analysts forecast that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.

Select Medical Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 25th. Shareholders of record on Wednesday, November 12th were given a $0.0625 dividend. The ex-dividend date of this dividend was Wednesday, November 12th. This represents a $0.25 annualized dividend and a yield of 1.6%. Select Medical’s payout ratio is currently 29.07%.

Analyst Ratings Changes

Several brokerages recently weighed in on SEM. Wall Street Zen raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Mizuho set a $17.00 target price on Select Medical in a report on Monday, November 3rd. Royal Bank Of Canada lifted their target price on Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Weiss Ratings reissued a “sell (d+)” rating on shares of Select Medical in a research report on Wednesday, October 8th. Finally, Benchmark reaffirmed a “buy” rating on shares of Select Medical in a report on Monday, October 27th. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $17.80.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.